The current paradigm of drugdevelopment is unsustainable as costs and investors’ aversion to risk continuesto increase. Non-profit research foundations are emerging as the architect ofinnovative collaborative models to overcome systemic obstacles and acceleratethe development of new therapeutic approaches.
Kathy Giusti, MBA 1985, isFounder and CEO of the Multiple Myeloma Research Foundation (MMRF), which hascompletely transformed the treatment landscape for this uncommon and fatalcancer and is lauded as a model for other diseases to emulate. She willshare her unique business model, review some of the challenges she hasovercome, and share her approach to the latest obstacle – building open accessdata platforms to speed drug discovery and development.
Date: Tuesday, February 12, 2013
Time: 12:00 noon - 1:00 pm ET
Location: Virtual. Dial-in information will be sent 24-hours prior to the call.
Cost: FREE for members; $50 non-members
For a completelisting of Virtual HC Roundtables, including past recordings and presentations,please click here.